Law Office of Hong-min Jun · Chicago · Indianapolis
Drug Development Specialist
Pharmaceutical Sciences & Oncology · South Korea
Dr. S.K. is a senior research scientist with a Ph.D. in Pharmaceutical Sciences from Seoul National University, specializing in oncology drug formulation. She had been conducting cutting-edge research at a top-20 U.S. pharmaceutical company for over 6 years, contributing to two FDA-approved cancer therapies. Her work focused on improving drug bioavailability for solid tumor treatment, directly impacting patient survival rates.
The primary challenge was demonstrating that her work had national importance beyond the pharmaceutical company's commercial interests. Reviewers at USCIS often scrutinize drug development cases to ensure the benefit extends to the broader U.S. population, not just the employer.
Her research directly addressed a critical gap in oncology treatment: low bioavailability of oral cancer drugs leads to higher dosages, greater toxicity, and reduced patient compliance. Her formulation innovations improved efficacy by 40%, with measurable patient outcome improvements documented in clinical trial data.
Cancer is the second leading cause of death in the U.S., with over 1.9 million new diagnoses annually per NCI data. Her work was cited in FDA regulatory submissions and aligned with the National Cancer Institute's strategic research priorities for improving oral chemotherapy accessibility.
Her employer could not be the petitioner under normal PERM due to competitive hiring concerns. Her research was time-sensitive — a delay in labor certification would set back clinical trial timelines by 18-24 months, jeopardizing the national benefit of her ongoing contributions.
This case succeeded because we shifted the narrative from "pharmaceutical company research" to "national public health infrastructure." By anchoring every argument to NCI priorities and FDA fast-track designations, we demonstrated that Dr. S.K.'s work had national importance independent of her employer. Expert letters from NCI-funded researchers — not just industry colleagues — were pivotal in establishing credibility.
USCIS Approval Notice
Client identity redacted for confidentiality
Attorney Hong-min Jun can evaluate whether your background qualifies for NIW under the Dhanasar framework.
Request Free ConsultationAnalysis of AAO decision approving NIW for renewable energy researcher — publication impact and national interest contribution.
Why many NIW petitions fail at the National Importance prong in 2025, based on AAO decisions and practical case experience.
How the AAO evaluates recommendation letters in NIW petitions and what makes expert letters truly effective.
Every successful NIW case starts with a strategic assessment. Attorney Hong-min Jun will analyze your background against the Dhanasar framework and identify the strongest evidence for your petition.
Schedule Your Consultation